DIAGNOS INC (ADK.CA) Stock Price, Forecast & Analysis

TSX-V:ADK • CA2524423068

0.3 CAD
0 (0%)
Last: Mar 2, 2026, 07:00 PM

ADK.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap36.12M
Revenue(TTM)79.00K
Net Income(TTM)-4.76M
Shares120.41M
Float107.12M
52 Week High0.42
52 Week Low0.18
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.05
PEN/A
Fwd PEN/A
Earnings (Next)03-04
IPO2000-09-27
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
ADK.CA short term performance overview.The bars show the price performance of ADK.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10

ADK.CA long term performance overview.The bars show the price performance of ADK.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20

The current stock price of ADK.CA is 0.3 CAD. In the past month the price increased by 1.69%. In the past year, price decreased by -4.76%.

DIAGNOS INC / ADK Daily stock chart

ADK.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ADK.CA. When comparing the yearly performance of all stocks, ADK.CA is a bad performer in the overall market: 85.82% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
ADK.CA Full Technical Analysis Report

ADK.CA Financial Highlights

Over the last trailing twelve months ADK.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -10.34% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -406.07%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%13.71%
Sales Q2Q%-30.91%
EPS 1Y (TTM)-10.34%
Revenue 1Y (TTM)-48.53%
ADK.CA financials

ADK.CA Forecast & Estimates


Analysts
Analysts84.44
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
ADK.CA Analyst EstimatesADK.CA Analyst Ratings

ADK.CA Ownership

Ownership
Inst Owners0.28%
Ins Owners4.12%
Short Float %N/A
Short RatioN/A
ADK.CA Ownership

About ADK.CA

Company Profile

ADK logo image Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.

Company Info

DIAGNOS INC

7005 Taschereau Blvd Suite 340

Brossard QUEBEC J4Z 1A7 CA

CEO: Andre Larente

Employees: 16

ADK Company Website

ADK Investor Relations

Phone: 14506788882

DIAGNOS INC / ADK.CA FAQ

Can you describe the business of DIAGNOS INC?

Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company is headquartered in Brossard, Quebec. The company went IPO on 2000-09-27. The company markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.


What is the stock price of DIAGNOS INC today?

The current stock price of ADK.CA is 0.3 CAD.


Does ADK stock pay dividends?

ADK.CA does not pay a dividend.


What is the ChartMill rating of DIAGNOS INC stock?

ADK.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Can you provide the sector and industry classification for DIAGNOS INC?

DIAGNOS INC (ADK.CA) operates in the Health Care sector and the Health Care Technology industry.